Vaccine strategies against schistosomiasis

Schistosomiasis, the second major parasitic disease in the world after malaria affects at least 200 million people, 500 million being exposed to the risk of infection. It is widely agreed that a vaccine strategy wich could lead to the induction of effector mechanisms reducing the level of reinfectio...

Full description

Bibliographic Details
Main Authors: A. Capron, J. P. Dessaint, M. Capron, R. J. Pierce
Format: Article
Language:English
Published: Instituto Oswaldo Cruz, Ministério da Saúde 1992-01-01
Series:Memórias do Instituto Oswaldo Cruz.
Subjects:
IgE
IgA
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000900001
id doaj-20a74a19fa67404089eabdc5b5183661
record_format Article
spelling doaj-20a74a19fa67404089eabdc5b51836612020-11-25T01:06:38ZengInstituto Oswaldo Cruz, Ministério da SaúdeMemórias do Instituto Oswaldo Cruz.0074-02761678-80601992-01-01871910.1590/S0074-02761992000900001Vaccine strategies against schistosomiasisA. CapronJ. P. DessaintM. CapronR. J. PierceSchistosomiasis, the second major parasitic disease in the world after malaria affects at least 200 million people, 500 million being exposed to the risk of infection. It is widely agreed that a vaccine strategy wich could lead to the induction of effector mechanisms reducing the level of reinfection and ideally parasite fecundity would deeply affect the incidence of pathological manifestations as well as the parasite transmission potentialities. Extensive studies performed in the rat model have allowed the identification of novel effector mechanisms involving IgE antibodies and various inflammatory cell populations (eosinophils, macrophages and platelets) whereas regulation of immune response by blocking antibodies has been evidencial. Recent epidemiological studies have now entirely confirmed in human populations the the role of IgE antibodies in the acquisition of resistance and the association of IgG4 blocking antibodies with increased susceptibility. On the basis of these concepts, several schistosome glutathion S-transferase (Sm 28 GST) appears as a pronising vaccine candidate. Immunization experiments have shown that two complementary goals can be achieved: (a) a partial but significant reduction of the worm population (up to 60//in rats); (b) a significant reduction of parasite fecundity (up in the mice and 85//in cattle) and egg viability (up to 80//). At least two distinct immunological mechanisms account for these two effects. IgE antibodies appear as a major humoral component of acquired resistance whereas IgA antibodies appear as a major humoral factor affecting parasite fecundity. These studies seem to represent a parasite diseases through the identification of potentially protective antigens and of the components of the immune response which vaccination should aim at inducing.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000900001schistosomiasisvaccineIgEIgAprotection
collection DOAJ
language English
format Article
sources DOAJ
author A. Capron
J. P. Dessaint
M. Capron
R. J. Pierce
spellingShingle A. Capron
J. P. Dessaint
M. Capron
R. J. Pierce
Vaccine strategies against schistosomiasis
Memórias do Instituto Oswaldo Cruz.
schistosomiasis
vaccine
IgE
IgA
protection
author_facet A. Capron
J. P. Dessaint
M. Capron
R. J. Pierce
author_sort A. Capron
title Vaccine strategies against schistosomiasis
title_short Vaccine strategies against schistosomiasis
title_full Vaccine strategies against schistosomiasis
title_fullStr Vaccine strategies against schistosomiasis
title_full_unstemmed Vaccine strategies against schistosomiasis
title_sort vaccine strategies against schistosomiasis
publisher Instituto Oswaldo Cruz, Ministério da Saúde
series Memórias do Instituto Oswaldo Cruz.
issn 0074-0276
1678-8060
publishDate 1992-01-01
description Schistosomiasis, the second major parasitic disease in the world after malaria affects at least 200 million people, 500 million being exposed to the risk of infection. It is widely agreed that a vaccine strategy wich could lead to the induction of effector mechanisms reducing the level of reinfection and ideally parasite fecundity would deeply affect the incidence of pathological manifestations as well as the parasite transmission potentialities. Extensive studies performed in the rat model have allowed the identification of novel effector mechanisms involving IgE antibodies and various inflammatory cell populations (eosinophils, macrophages and platelets) whereas regulation of immune response by blocking antibodies has been evidencial. Recent epidemiological studies have now entirely confirmed in human populations the the role of IgE antibodies in the acquisition of resistance and the association of IgG4 blocking antibodies with increased susceptibility. On the basis of these concepts, several schistosome glutathion S-transferase (Sm 28 GST) appears as a pronising vaccine candidate. Immunization experiments have shown that two complementary goals can be achieved: (a) a partial but significant reduction of the worm population (up to 60//in rats); (b) a significant reduction of parasite fecundity (up in the mice and 85//in cattle) and egg viability (up to 80//). At least two distinct immunological mechanisms account for these two effects. IgE antibodies appear as a major humoral component of acquired resistance whereas IgA antibodies appear as a major humoral factor affecting parasite fecundity. These studies seem to represent a parasite diseases through the identification of potentially protective antigens and of the components of the immune response which vaccination should aim at inducing.
topic schistosomiasis
vaccine
IgE
IgA
protection
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000900001
work_keys_str_mv AT acapron vaccinestrategiesagainstschistosomiasis
AT jpdessaint vaccinestrategiesagainstschistosomiasis
AT mcapron vaccinestrategiesagainstschistosomiasis
AT rjpierce vaccinestrategiesagainstschistosomiasis
_version_ 1725189045355544576